News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
92 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28348)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3627)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (86)
3 (15)
4 (48)
5 (127)
6 (194)
7 (194)
8 (195)
9 (1)
11 (65)
12 (179)
13 (158)
14 (111)
15 (154)
18 (92)
19 (92)
20 (119)
21 (100)
22 (68)
24 (15)
25 (85)
26 (125)
27 (76)
28 (174)
29 (117)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
11
12
13
14
15
18
19
20
21
22
24
25
26
27
28
29
Rare diseases
FDA Rejects PTC Therapeutics’ Friedreich’s Ataxia Drug
The small molecule, vatiquinone, had already flunked a Phase III trial, but the company pushed ahead with an approval bid anyway.
August 19, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research
August 19, 2025
·
6 min read
Press Releases
BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery
August 19, 2025
·
2 min read
Press Releases
OS Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
August 19, 2025
·
10 min read
Press Releases
Hemostemix Announces Its AI Strategy
August 19, 2025
·
8 min read
Press Releases
Active Pharmaceutical Ingredients Market Size is to Reach USD 428.5 Billion by 2033, with a 6.8% CAGR Growth, Report by DataM Intelligence
August 19, 2025
·
1 min read
Press Releases
Rare Disease Therapeutics Market Projected to Reach US$ 495.27 Billion by 2033, Says DataM Intelligence
August 19, 2025
·
1 min read
Press Releases
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
August 19, 2025
·
2 min read
Press Releases
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
August 19, 2025
·
12 min read
Press Releases
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
August 19, 2025
·
8 min read
Previous
9 of 10
Next
